Autonomic Neuroscience Unit
Short description
Our research studies how the autonomic nervous system is affected by disease and how this knowledge may contribute to future drug development.
Our research
Our research focuses on the autonomic nervous system and how its function is altered in different diseases. By combining pharmacology and physiology, we investigate biological processes in relevant disease models.
A key aim is to understand how normal physiological mechanisms change during disease development. To achieve this, we use a broad range of pharmacological tools and experimental methods.
Our long-term ambition is to identify therapeutic targets that may form the basis for future drug development and contribute to new treatment strategies.
Current research projects
The role of nitric oxide in the lower urinary tract
Principal investigator: Michael Winder
Purinergic and hormonal signalling, and interactions between signalling systems
Principal investigator: Patrik Aronsson
Inflammatory diseases of the lower urinary tract: the link between bladder function and chronic prostatitis
Principal investigator: Michael Winder
Autonomic dysfunction in Parkinson’s disease
Principal investigator: Thomas Carlsson
Secretory mechanisms in the lacrimal and salivary glands
Principal investigator: Michael Winder
Novel compounds with effects on the lower urinary tract
Principal investigator: Gunnar Tobin
The use of cannabinoids in the treatment of prostate cancer
Principal investigator: Michael Winder
Group members
Researchers
Michael Winder, Professor, Principal Investigator
Patrik Aronsson, Associate Professor
Thomas Carlsson, Associate Professor
Gunnar Tobin, Professor Emeritus
Özgü Aydogdu, affiliated researcher
Doctoral students
Arghavan Azadi, medical science
Gwenaelle Black, basic medicine
Renata Vesela, farmaceutical science
Technical staff
Jenny Steen, Biomedical Scientist